InsightRX Apollo for Providers
Drug Performance Data, Available in Real-time
Empower your pharmacy to continuously improve medication safety and operational efficiency with instant access to clinical and performance analytics.

InsightRX Nova
Core features and capabilities


Measure impact through data
Track key operational metrics — like turnaround time, adverse events, and dosing success — all in real time. Demonstrate program value with data-driven insights.

360°-visibility into medication performance
Observe clinical outcomes by drug, demographic group, or adverse event type using interactive, filterable dashboards. Spot trends and outliers quickly.



Generate Joint Commission-ready reports in seconds
Joint Commission Standard MM.08.01.01 calls for hospitals to regularly evaluate the effectiveness of medication management systems. View performance and clinical outcomes instantly, eliminating the need for data pull requests with lengthy lag times.
Additional Information
Learn more about our products and services:
Utilize the Gold-Standard in Bayesian MIPD
Individualize therapy with Bayesian dosing support that adapts to each patient. InsightRX Nova clinical decision software helps you personalize doses at the point of care, reaching therapeutic targets faster and helping clinicians proactively reduce adverse drug events.
Harness Continuous Model Improvement and Retraining
A cornerstone of our platform, InsightRX Continuous Learning process retrains models on real-world outcomes, improving predictive accuracy over time. This framework helps keep your pharmacy practice current, reliable, and clinically relevant.
Trusted Security and Regulatory Standards
At InsightRX, we adhere to the highest standards of data security, regulatory compliance, and clinical software quality — including CE marking and HITRUST certification, and alignment with ISO 13485 and GxP guidelines. Our commitment ensures our software and services are secure, validated and trusted by healthcare providers to help deliver exceptional patient care.